![EPIRIUM BIO](https://parsers.vc/logo/691c2155-24e8-4c25-9cc9-3dfb1ad222b8-0.jpg)
Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.
Location: Canada
Employees: 11-50
Total raised: $85M
Founded date: 2008
Investors 5
Date | Name | Website |
- | The Longev... | longevity.... |
17.07.2021 | ARCH Ventu... | archventur... |
- | BlueBird V... | bluebirdvc... |
- | Adams Stre... | adamsstree... |
- | Longitude ... | longitudec... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
22.12.2019 | Series A | $85M | - | vcnewsdail... |
Mentions in press and media 5
Date | Title | Description | Source |
23.09.2020 | Healthcare VC Firm Longitude Capital Closes $585M Fund | What You Should Know: – Healthcare venture capital firm Longitude Capital announces the close of it... | hitconsult... |
23.09.2020 | Longitude Capital Raises $585 Million Fund to Invest in Tran... | - Longitude Venture Partners IV will build on the Firm’s commitment to improve clinical outcomes, en... | marketscre... |
22.12.2019 | Epirium Raises $85 Million to Treat Muscle Diseases | Epirium surfaced Dec... Take 1 minute to subscribe and you'll get this story immediately, plus: Al... | sdbj.com/n... |
19.12.2019 | Epirium Raises $85M in Hopes of Treating Muscle Diseases | - | connect.or... |
19.12.2019 | Epirium Bio Scores $85M Series A | SAN FRANCISCO, CA, Epirium Bio today announced it has raised $85 million in Series A financing. &... | vcnewsdail... |